Similarweb to Announce Second Quarter 2025 Financial Results on August 12, 2025, After Market Close
Management will host a conference call on Wednesday, August 13, 2025, at 8:30 a.m. EST to discuss the Company's business and financial results. A live webcast of the call can be accessed from Similarweb's Investor Relations website at https://ir.similarweb.com. An archived webcast of the conference call will also be made available on the Similarweb website following the call. The live call may also be accessed via telephone at (877) 407-0726 toll-free and at (201) 689-7806 internationally.
About Similarweb
Similarweb powers businesses to win their markets with Digital Data. By providing essential web and app data, analytics, and insights, we empower our users to discover business opportunities, identify competitive threats, optimize strategy, acquire the right customers, and increase monetization. Similarweb products are integrated into users' workflow, powered by advanced technology, and based on leading comprehensive Digital Data.
Learn more: Similarweb | Similarweb Digital Data | Similarweb Investor Relations | Similarweb Press Data
Free Tools: Analyze any website or app | Verify your website | Browser extension
Follow us: Blog | LinkedIn | YouTube | Instagram | X
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Why Revvity (RVTY) Stock Is Falling Today
What Happened? Shares of life sciences company Revvity (NYSE:RVTY) fell 7.6% in the afternoon session after the company lowered its full-year profit forecast, which overshadowed its second-quarter earnings and revenue beat. Despite reporting second-quarter revenue of $720 million and an adjusted earnings per share (EPS) of $1.18, both of which surpassed analyst expectations, investors focused on the weaker outlook. Revvity trimmed its full-year adjusted EPS guidance to a range of $4.85 to $4.95. This revision was driven by multiple headwinds, including a double-digit decline in its diagnostics revenue from China, a key international market. The company also faced shrinking profitability, as both its adjusted operating and gross margins fell compared to the previous year. Management also pointed to potential costs related to tariffs. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Revvity? Access our full analysis report here, it's free. What Is The Market Telling Us Revvity's shares are not very volatile and have only had 9 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The previous big move we wrote about was 10 days ago when the stock dropped 3.2% as several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively. Additionally, some pharmaceutical and biotech companies experienced sharp drops following unfavorable news; for instance, Sarepta Therapeutics plunged after a report indicated another patient death tied to its experimental gene therapy, and GSK's blood cancer drug dosage was voted against by the FDA advisory committee. Broader market sentiment, including concerns about rising costs and inadequate pricing for 2025 plans among health insurers, also contributed to the downward pressure on healthcare equities. Revvity is down 14.7% since the beginning of the year, and at $95.58 per share, it is trading 25.2% below its 52-week high of $127.75 from September 2024. Investors who bought $1,000 worth of Revvity's shares 5 years ago would now be looking at an investment worth $845.92. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
Why Xponential Fitness (XPOF) Stock Is Trading Up Today
What Happened? Shares of boutique fitness studio franchisor Xponential Fitness (NYSE:XPOF) jumped 3.4% in the pre-market session after the company announced it had completed the divestiture of its CycleBar and Rumble brands. The fitness franchisor sold the two brands to Extraordinary Brands, LLC, as part of a strategic realignment. Xponential Fitness stated that the transaction was consistent with its plan to focus resources and capital on its more profitable brands. In a statement, CEO Mark King emphasized that the company would concentrate on brands that drove both current and long-term profitability. This move was presented as a strategic effort to improve the company's financial performance and provide better support for its core, higher-performing franchises. After the initial pop the shares cooled down to $11.01, up 2.3% from previous close. Is now the time to buy Xponential Fitness? Access our full analysis report here, it's free. What Is The Market Telling Us Xponential Fitness's shares are extremely volatile and have had 50 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 25 days ago when the stock gained 34.1% on the news that the company announced that the U.S. Securities and Exchange Commission (SEC) has concluded its investigation into the company without recommending any enforcement action. The investigation, which began in December 2023, had been a significant overhang on the company's stock, which has fallen approximately 45% year-to-date. The probe was initiated after the SEC requested documents related to potential securities fraud and accounting issues. In a filing, Xponential stated it was informed on July 1 that the investigation was concluded and that no action would be taken. The company noted it had fully cooperated with the regulator over the past 18 months. This news removed a major cloud of uncertainty for investors, leading to a surge in confidence as reflected in the pre-market rally. Analysts at Jefferies noted that with the probe now cleared and new leadership in place, investor sentiment should improve, potentially allowing the stock's valuation to rise toward peer levels as the company focuses on its growth plans. Xponential Fitness is down 21.1% since the beginning of the year, and at $11.01 per share, it is trading 40.4% below its 52-week high of $18.47 from February 2025. Investors who bought $1,000 worth of Xponential Fitness's shares at the IPO in July 2021 would now be looking at an investment worth $898.78. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
Yahoo
25 minutes ago
- Yahoo
Yacktman Focused Fund's Strategic Move: Compagnie de l'Odet Takes Center Stage
Exploring the Latest Investment Decisions of Yacktman Focused Fund (Trades, Portfolio) Warning! GuruFocus has detected 3 Warning Signs with XKRX:005935. Yacktman Focused Fund (Trades, Portfolio) recently submitted its N-PORT filing for the second quarter of 2025, shedding light on its strategic investment decisions during this period. Managed by Yacktman Asset Management (Trades, Portfolio), the fund is renowned for its pursuit of long-term capital appreciation, with a secondary focus on current income. As a non-diversified fund, it primarily invests in common stocks of both domestic and foreign companies, regardless of size, with a preference for those that pay dividends. The investment team is known for its objective, patient, and diligent approach, making decisions based on the intrinsic merits of individual securities rather than attempting to predict market trends. Yacktman employs a disciplined strategy, seeking growth companies at attractive valuations, effectively blending "growth" and "value" investing principles. The fund typically targets companies with strong business models, shareholder-oriented management, and low purchase prices. Summary of New Buy Yacktman Focused Fund (Trades, Portfolio) added a total of one stock to its portfolio this quarter: The most significant addition was Compagnie de l'Odet (XPAR:ODET), with 12,846 shares, accounting for 0.95% of the portfolio and a total value of 22.58 million. Key Position Reduces Yacktman Focused Fund (Trades, Portfolio) also reduced its position in 21 stocks. The most significant changes include: Reduced Canadian Natural Resources Ltd (NYSE:CNQ) by 700,000 shares, resulting in a -9.09% decrease in shares and a -0.92% impact on the portfolio. The stock traded at an average price of $30.31 during the quarter and has returned 9.41% over the past 3 months and 6.32% year-to-date. Reduced Bollore SE (XPAR:BOL) by 3,500,000 shares, resulting in a -7.87% reduction in shares and a -0.88% impact on the portfolio. The stock traded at an average price of 5.4 during the quarter and has returned 2.08% over the past 3 months and -8.92% year-to-date. Portfolio Overview As of the second quarter of 2025, Yacktman Focused Fund (Trades, Portfolio)'s portfolio comprised 40 stocks. The top holdings included 13.76% in Samsung Electronics Co Ltd (XKRX:005935), 10.86% in Bollore SE (XPAR:BOL), 9.26% in Canadian Natural Resources Ltd (NYSE:CNQ), 4.82% in Microsoft Corp (NASDAQ:MSFT), and 4.02% in Hyundai Mobis Co Ltd (XKRX:012330). The holdings are primarily concentrated in nine of the eleven industries: Communication Services, Technology, Consumer Defensive, Energy, Consumer Cyclical, Industrials, Basic Materials, Financial Services, and Healthcare. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
